Emesis induced by low or minimal emetic risk chemotherapy

@article{Tonato2004EmesisIB,
  title={Emesis induced by low or minimal emetic risk chemotherapy},
  author={Maurizio Tonato and Rebecca Anne Clark-Snow and David Osoba and Albano Del Favero and Enzo Ballatori and Sussanne Borjeson},
  journal={Supportive Care in Cancer},
  year={2004},
  volume={13},
  pages={109-111}
}
For patients treated with low or minimally emetogenic chemotherapy there is little evidence from clinical trials supporting the choice of a given antiemetic therapy or of any treatment at all. The panel recognized the necessity of considering the introduction into clinical practice of new agents in these categories, particularly oral cytotoxic agents and targeted biological agents and also the possibility of over-treatment with antiemetics. There was consensus among panel members regarding the… CONTINUE READING

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-4 OF 4 REFERENCES

Cancer chemotherapy-induced delayed emesis: antiemetic prescriptions in clinical practice

V DeAngelis, F Roila, R Sabbatini
  • ASCO abstract
  • 2003

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1999
VIEW 1 EXCERPT